PNPLA3 and coronary artery disorder: PNPLA3 is predominantly expressed in hepatocytes and hepatic stellate cells, exhibiting hydrolytic activity against triglycerides (TGs) and retinol, thereby mitigating the risk of coronary heart disease.22